Abatacept + Adalimumab Ryvk Interaction
Majorinteraction on record
Description
Increased risk of serious infection when combined with adalimumab-ryvk. Not recommended in patients with RA.
Mechanism
TNF blocker combined with biologic DMARD
Source: NLP:adalimumab-ryvk